What's in Iterum Therapeutics, International Limited's pipeline?

Iterum Therapeutics, International Limited has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Iterum Therapeutics, International Limited's portfolio?

Top competitors by shared drug class: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Merck Sharp & Dohme LLC, Neutec Ar-Ge San ve Tic A.Ş, Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/iterum-therapeutics-international-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Iterum Therapeutics, International Limited — Portfolio Competitive Intelligence Brief

Iterum Therapeutics, International Limited pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
sulopenem etzadroxil and probenecid	sulopenem etzadroxil and probenecid	marketed
Sulopenem Etzadroxil/Probenecid	Sulopenem Etzadroxil/Probenecid	phase 3	carbapenem antibiotic	bacterial cell wall synthesis	Infectious Diseases

Therapeutic area mix

Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
Neutec Ar-Ge San ve Tic A.Ş · 1 shared drug class
Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Iterum Therapeutics, International Limited:

Cite this brief

Drug Landscape (2026). Iterum Therapeutics, International Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/iterum-therapeutics-international-limited. Accessed 2026-05-16.